That’s where ETFs come in. How can anyone know which biotechnology companies will be winners in the long run? ETFs help spread out the risk and eliminate the need for guesswork and single-stock picking. (Read more about the biotechnology sector).
If you decide this sector is right for your investment needs, go in with a strategy in place and a stop-loss in mind. (How to follow the trends).
For more stories about biotechnology, visit our biotechnology category.
- PowerShares Dynamic Biotech & Genome (NYSEArca: PBE): up 18.2% year-to-date
- SPDR S&P Biotechnology (NYSEArca: XBI): down 4.5% year-to-date
